Literature DB >> 21469088

Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity.

Kaleb M Pauley1, Carol M Stewart, Adrienne E Gauna, Lauren C Dupre, Riya Kuklani, Annie L Chan, Brad A Pauley, Westley H Reeves, Edward K L Chan, Seunghee Cha.   

Abstract

MicroRNAs (miRNAs), small non-coding RNA molecules that post-transcriptionally regulate gene expression, are known to play key roles in regulating immune responses and autoimmunity. We investigated miR-146a expression in Sjögren's syndrome (SjS) patients as well as in the SjS-prone C57BL/6.NOD-Aec1Aec2 mouse model, to elucidate its involvement in SjS pathogenesis. Expression of miR-146a was examined in the PBMCs of 25 SjS patients and ten healthy donors, as well as in PBMCs, salivary and lacrimal glands of SjS-prone mice and WT C57BL/6J mice. Functional assays using THP-1 human monocytes were conducted to determine the biological roles of miR-146a in innate immunity. Expression of miR-146a was significantly increased in SjS patients compared with healthy controls, and was upregulated in the salivary glands and PBMCs of the SjS-prone mouse at both 8 wk (prior to disease onset) and 20 wk (full-blown disease) of age. More importantly, functional analysis revealed roles for miR-146a in increasing phagocytic activity and suppressing inflammatory cytokine production while migration, nitric oxide production and expression of antigen-presenting/costimulatory molecules are not affected in human monocytic THP-1 cells. Taken together, our data suggest that abnormal expression/regulation of microRNAs in innate immunity may contribute to, or be indicative of, the initiation and progression of SjS.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21469088      PMCID: PMC3760391          DOI: 10.1002/eji.201040757

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  32 in total

1.  MicroRNA-155 is induced during the macrophage inflammatory response.

Authors:  Ryan M O'Connell; Konstantin D Taganov; Mark P Boldin; Genhong Cheng; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

2.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

3.  Salivary gland cytokine expression in NOD and normal BALB/c mice.

Authors:  S Yamano; J C Atkinson; B J Baum; P C Fox
Journal:  Clin Immunol       Date:  1999-09       Impact factor: 3.969

4.  A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.

Authors:  S Cha; J Brayer; J Gao; V Brown; S Killedar; U Yasunari; A B Peck
Journal:  Scand J Immunol       Date:  2004-12       Impact factor: 3.487

5.  Early pathogenic events associated with Sjögren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis.

Authors:  Smruti J Killedar; Smruti Y Killedar; Sarah E Eckenrode; Richard A McIndoe; Jin-Xiong She; Cuong Q Nguyen; Ammon B Peck; Seunghee R Cha; Seunghee Cha
Journal:  Lab Invest       Date:  2006-10-30       Impact factor: 5.662

6.  Circulating cytokines in primary Sjögren's syndrome determined by a multiplex cytokine array system.

Authors:  P Szodoray; P Alex; J G Brun; M Centola; R Jonsson
Journal:  Scand J Immunol       Date:  2004-06       Impact factor: 3.487

7.  Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.

Authors:  Seunghee Cha; Hiroyuki Nagashima; Vinette B Brown; Ammon B Peck; Michael G Humphreys-Beher
Journal:  Arthritis Rheum       Date:  2002-05

8.  Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice.

Authors:  C P Robinson; H Yamamoto; A B Peck; M G Humphreys-Beher
Journal:  Clin Immunol Immunopathol       Date:  1996-04

9.  MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?

Authors:  Enikö Sonkoly; Tianling Wei; Peter C J Janson; Annika Sääf; Lena Lundeberg; Maria Tengvall-Linder; Gunnar Norstedt; Harri Alenius; Bernhard Homey; Annika Scheynius; Mona Ståhle; Andor Pivarcsi
Journal:  PLoS One       Date:  2007-07-11       Impact factor: 3.240

10.  Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.

Authors:  Michele Bombardieri; Francesca Barone; Valerio Pittoni; Cristiano Alessandri; Paola Conigliaro; Mark C Blades; Roberta Priori; Iain B McInnes; Guido Valesini; Costantino Pitzalis
Journal:  Arthritis Res Ther       Date:  2004-08-03       Impact factor: 5.156

View more
  69 in total

Review 1.  Association of MicroRNA-146a with autoimmune diseases.

Authors:  Wang-Dong Xu; Man-Man Lu; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

Review 2.  Functional regulation of monocyte-derived dendritic cells by microRNAs.

Authors:  Yifan Zhan; Li Wu
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

3.  Upregulation of long noncoding RNA TMEVPG1 enhances T helper type 1 cell response in patients with Sjögren syndrome.

Authors:  Juan Wang; Huiyong Peng; Jie Tian; Jie Ma; Xinyi Tang; Ke Rui; Xinyu Tian; Yungang Wang; Jianguo Chen; Liwei Lu; Huaxi Xu; Shengjun Wang
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

4.  Autoantigen-targeting microRNAs in Sjögren's syndrome.

Authors:  Ying Yang; Linyi Peng; Weizhi Ma; Fan Yi; Zhenxi Zhang; Hua Chen; Yongqing Guo; Li Wang; Li Dan Zhao; Wenjie Zheng; Jinghui Li; Fengchun Zhang; Quan Du
Journal:  Clin Rheumatol       Date:  2016-02-18       Impact factor: 2.980

5.  miRNA-146a in rheumatoid arthritis: a new therapeutic strategy.

Authors:  Kaleb M Pauley; Seunghee Cha
Journal:  Immunotherapy       Date:  2011-07       Impact factor: 4.196

6.  miR-146a-Traf6 regulatory axis controls autoimmunity and myelopoiesis, but is dispensable for hematopoietic stem cell homeostasis and tumor suppression.

Authors:  Nathaniel Magilnick; Estefany Y Reyes; Wei-Le Wang; Steven L Vonderfecht; Jin Gohda; Jun-Ichiro Inoue; Mark P Boldin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

Review 7.  Mechanistic biomarkers for clinical decision making in rheumatic diseases.

Authors:  William H Robinson; Tamsin M Lindstrom; Regina K Cheung; Jeremy Sokolove
Journal:  Nat Rev Rheumatol       Date:  2013-02-19       Impact factor: 20.543

Review 8.  Update on Pathogenesis of Sjogren's Syndrome.

Authors:  Pulukool Sandhya; Biji Theyilamannil Kurien; Debashish Danda; Robert Hal Scofield
Journal:  Curr Rheumatol Rev       Date:  2017

Review 9.  MicroRNAs--novel regulators of systemic lupus erythematosus pathogenesis.

Authors:  Nan Shen; Dong Liang; Yuanjia Tang; Niek de Vries; Paul-Peter Tak
Journal:  Nat Rev Rheumatol       Date:  2012-10-16       Impact factor: 20.543

10.  Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis.

Authors:  JunMei Zhang; Ge Jia; Qun Liu; Jue Hu; Mei Yan; BaiFeng Yang; Huan Yang; WenBin Zhou; Jing Li
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.